Biological role of HGF/MET pathway in renal cell carcinoma

Journal of Urology

Volumn 161, Issue 3, 1999, Pages 990-997

  Horie, Shigeo ^a   Aruga, Seiji ^b   Kawamata, Hitoshi ^b   Okui, Nobuo ^b   Kakizoe, Tadao ^b   Kitamura, Tadaichi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

Apoptosis; Fas; HGF; MET; MMP 9; Renal cell carcinoma

Indexed keywords

COMPLEMENTARY DNA; FAS ANTIGEN; GELATINASE A; METALLOPROTEINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CANCER GROWTH; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032826272     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61834-2     Document Type: Article

References (43)

1. Harris, D. T.: Hormonal therapy and chemotherapy of renal cell carcinoma. Sem. Oncol., 10: 422, 1983.
2. Finney, R.: The value of radiotherapy in the treatment of hypernephroma-a clinical trial. Brit. J. Urol., 45: 258, 1973.
3. Kerr, J. F. R., Winterford, C. M. and Harmon, B. V. Apoptosis: its significance in cancer and cancer therapy. Cancer, 73: 2013, 1994.
4. Fisher, D. E.: Apoptosis in cancer therapy: crossing the threshold. Cell. 78: 539, 1994.
5. Cantley, L. G., Barros, E. J. G., Gandhi, M., Rauchman, M. and Nigan, S. K.: Regulation of mitogenesis, mutagenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am. J. Physiol., 267: F271, 1994.
6. Matsumoto, K. and Nakamura, T.: Emerging multipotent aspects of hepatocyte growth factor. J. Biochem., 119: 591, 1996.
7. Montesano, R., Matsumoto, K., Nakamura, T. and Orci, L.: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell, 67: 901, 1991.
8. Bellusci, S., Moens, G., Gaudino, G., Comoglio, P., Nakamura, T., Thiery, J. P. and Jouanneau, J.: Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene, 9: 1091, 1994.
9. Jeffers, M., Rong, S. and Woude, G. F. V.: Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/ scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol., 16: 1115, 1996.
10. Natali, P. G., Prat, M., Nicotra, M. R., Bigotti, A., Olivero, M., Comoglio, P. M. and Di Renzo, M. F.: Overexpression of the met/HGF receptor in renal cell carcinomas. Int. J. Cancer, 69: 212, 1996.
11. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U. R., Feltis, J. T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C. J., Walther, M. M., Tsui, L. C., Geil, L., Orcutt, M. L., Stackhouse, T. and Zbar, B.: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet., 16: 68, 1997.
12. Pisters, L. L., El-Naggar, A. K., Luo, W., Malpica, A. and Lin, S. H.: C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol., 158: 724, 1997.
13. Yoshinaga, Y., Matsuno, Y., Fujita, S., Nakamura, T., Kikuchi, M., Shimosato, Y. and Hirohashi, S.: Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn. J. Cancer Res., 84: 1150, 1993.
14. Riedy, M. C., Timm, E. A. Jr. and Stewart, C. C.: Quantitative RT-PCR for measuring gene expression. Biotechniques, 18: 70, 1995.
15. To, C. T. T. and Tsao, M. S.: The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers. Oncol. Rep., 5: 1013, 1998.
16. Nagata, S. and Golstein, P.: The Fas death factor. Science, 267: 1449, 1995.
17. Leithäiser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K. M., Krammer, P. H. and Möller, P.: Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest., 69: 415, 1993.
18. Chomczynski, P. and Sacchi, N.: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
19. Cottrez, F., Auriault, C., Capron, A. and Groux, H.: Quantitative PCR: validation of the use of a multispecific internal control. Nucleic Acids Res., 22: 2712, 1994.
20. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. and Shimizu, S.: Molecular cloning and expression of human hepatocyte growth factor. Nature, 342: 440, 1989.
21. Matano, T., Odawara, T., Ohshima, M., Yoshikura, H. and Iwamoto, A.: Trans-dominant interference with virus infection at two different stages by a mutant envelope protein of friend murine leukemia virus. J. Virol., 67: 2026, 1993.
22. Horie, S., Moe, O., Yamaji, Y., Cano, M., Miller, R. T. and Alpern, R. J.: Role of protein kinase C and transcription factor AP-1 in the acid-induced increase in Na/H antiporter activity. Proc. Natl. Acad. Sci. USA, 89: 5236, 1992.
23. Melchiori, A., Albini, A., Ray, J. M. and Stetler-Stevenson, W. G.: Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res., 52: 2353, 1992.
24. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W. and Martin, G. R.: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry, 21: 6188, 1982.
25. Kawamata, H., Kameyama, S., Kawai, K., Tanaka, Y., Nan, L., Barch, D. H., Stetler-Stevenson, W. G. and Oyasu, R.: Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A. Int. J. Cancer, 63: 568, 1995.
26. Mosmann, T.: Rapid calorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55, 1983.
27. Horie, S., Kano, M., Higashihara, E., Moriyama, N., Tanaka, E., Hirose, A., Kakizoe, T. and Kawabe, K.: The expression of Fas in renal cell carcinoma. Jpn. J. Clin. Oncol., 27: 384, 1997.
28. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J. and Mountz, J. D.: Protection from Fas-mediated apoptosis by a soluble from of the Fas molecule. Science, 263: 1759, 1994.
29. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A. and Seldin, M. F.: Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA, 92: 8443, 1995.
30. Sesler, S., Nakamura, T. and Byers, S.: Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-b activation. Endocrinology, 136: 1945, 1995.
31. Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A. and Merlino, G.: Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA, 94: 701, 1997.
32. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., Dilks, D. W. and Muschel, R. J.: Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis, 14: 246, 1994.
33. Bernhard, E. J., Gruber, S. B. and Muschel, R. J.: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91: 4293, 1994.
34. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickloff, B. J., Kinsella, J. L., Polverini, P. and Rosen, E. M.: Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA, 90: 1937, 1993.
35. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R. and Jones, R. J.: Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811, 1995.
36. Wu, X., Fan, Z., Masui, H., Rosen, N. and Mendelson, J.: Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest., 95: 1897, 1995.
37. Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y. and Fontana, A. Anti-Fas Antibody-mediated apoptosis of cultured human glioma cells: Induction and modulation of sensitivity by cytokines. J. Clin. Invest., 94: 954, 1994.
38. Jaattela, M., Benedict, M., Tewari, M., Shayman, J. A. and Dixit, V. M.: Bcl-x and bcl-2 inhibit TNF and fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10: 2297, 1995.
39. Lipponen, P., Eskelinen, M. and Syrjänen, K.: Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br. J. Cancer, 71: 863, 1995.
40. Halaban, R., Rubin, J. S., Funasaka, Y., Cobb, M., Boulton, T., Faletto, D., Rosen, E., Chan, A., Yoko, K., White, W., Cook, C. and Moellmann, G.: Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene, 7: 2195, 1992.
41. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, J. S. and Spiegel, S.: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381: 800, 1996.
42. Targonski, P. V., Frank, W., Stuhldreher, D. and Guinan, P. D.: Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J. Urol., 152: 1389, 1994.
43. Tsukamoto, T., Kumamoto, Y., Takahashi, A., Yanase, M., Yamazaki, K., Miyao, N., Masumori, N., Otani, N. and Satoh, M.: Tumor size of renal cell carcinoma: its clinical implication. Urol. Int., 48: 378, 1992.